York Bridge Wealth Partners, LLC Grifols Sa Transaction History

York Bridge Wealth Partners, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 21, 2019	SELL	$19.85 - $22.76 $148,279 - $170,017	-7,470 Closed	0 $0
Q2 2019 Jul 18, 2019	SELL	$17.59 - $21.1 $703 - $844	-40 Reduced 0.53%	7,470 $158,000
Q1 2019 May 09, 2019	BUY	$18.01 - $20.11 $6,141 - $6,857	341 Added 4.76%	7,510 $151,000
Q4 2018 Feb 14, 2019	SELL	$17.44 - $21.53 $6,226 - $7,686	-357 Reduced 4.74%	7,169 $132,000
Q2 2018 Aug 10, 2018	BUY	$20.16 - $24.68 $32,256 - $39,488	1,600 Added 27.0%	7,526 $162,000
Q1 2018 May 15, 2018	BUY	$20.31 - $24.95 $18,055 - $22,180	889 Added 17.65%	5,926 $125,000
Q4 2017 Feb 12, 2018	BUY	$20.99 - $23.89 $24,201 - $27,545	1,153 Added 29.69%	5,037 $115,000
Q3 2017 Oct 27, 2017	BUY	$20.07 - $21.89 $742 - $809	37 Added 0.96%	3,884 $85,000
Q2 2017 Aug 14, 2017	BUY	N/A	3,847	3,847 $81,000

164

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.33B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of York Bridge Wealth Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on York Bridge Wealth Partners, LLC with notifications on news.